These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 1834848)

  • 21. The efficacy of amlodipine in the management of ischaemic heart disease.
    McGibney D
    Postgrad Med J; 1991; 67 Suppl 3():S24-8. PubMed ID: 1836871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy.
    Chrysant SG; Bakris GL
    Am J Hypertens; 2004 Jul; 17(7):590-6. PubMed ID: 15233978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients.
    Zheng S; Nath V; Coyne DW
    Am J Nephrol; 2007; 27(5):522-9. PubMed ID: 17700014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benazepril plus amlodipine or hydrochlorothiazide for hypertension.
    Davis BR; Whelton PK;
    N Engl J Med; 2009 Mar; 360(11):1148-9; author reply 1149-50. PubMed ID: 19283889
    [No Abstract]   [Full Text] [Related]  

  • 27. Amlodipine: a once daily calcium antagonist.
    Burges RA
    J Hum Hypertens; 1991 Aug; 5 Suppl 1():49-54. PubMed ID: 1834846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipine.
    Corea L; Cardoni O; Fogari R; Innocenti P; Porcellati C; Provvidenza M; Meilenbrock S; Sullivan J; Bodin F
    Clin Pharmacol Ther; 1996 Sep; 60(3):341-6. PubMed ID: 8841157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of amlodipine in patients with mild-to-moderate hypertension.
    Olvera R; Samaniego V; Moguel R; Meaney E
    Int J Clin Pharmacol Res; 1991; 11(5):237-41. PubMed ID: 1839988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B
    Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of the calcium antagonist amlodipine on blood pressure and platelet aggregation in hypertensive patients.
    Hernández R; Carvajal AR; Armas-de Hernández MJ; Guerrero-Pajuelo J; Armas-Padilla MC; Barragán O; Machado-de Alvarado I
    Postgrad Med J; 1991; 67 Suppl 5():S38-40. PubMed ID: 1839438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
    Saito I; Saruta T;
    Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects.
    Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of aliskiren, a direct renin inhibitor, in the treatment of hypertension.
    Gradman AH; Traub D
    Rev Cardiovasc Med; 2007; 8 Suppl 2():S22-30. PubMed ID: 17401313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Twenty-four-hour blood pressure control using once daily treatment with a calcium antagonist or an angiotensin converting enzyme inhibitor.
    Malacco E; Fogari R; Tettamanti F; Magenta M
    J Hypertens Suppl; 1991 Dec; 9(6):S372-3. PubMed ID: 1840198
    [No Abstract]   [Full Text] [Related]  

  • 37. A review of amlodipine in myocardial ischaemia.
    Taylor SH
    Postgrad Med J; 1991; 67 Suppl 5():S48-51. PubMed ID: 1839440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amlodipine compared to nitrendipine in hypertensive patients: the effects on toleration in relationship to the onset of action.
    Waeber B; Borges ET; Christeler P; Guillaume-Gentil M; Hollenstein U; Mannhart M
    Cardiology; 1992; 80 Suppl 1():46-53. PubMed ID: 1534715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter placebo-controlled comparison of amlodipine and atenolol in mild to moderate hypertension.
    de Bruijn B; Cocco G; Tyler HM
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S107-9. PubMed ID: 2467117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profiles of calcium antagonists in cardiovascular disease with special reference to second-generation agents and amlodipine.
    Opie LH
    Postgrad Med J; 1991; 67 Suppl 5():S2-8. PubMed ID: 1666430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.